| Message | Subject | Recs | Date/Time (ET) |
| Is your criticism that SGMO appears to be over promising and that you do not bel | biotech firesales | | 03/07/2013 06:44:27 PM |
| Maybe approval with phase 4 trial to verify safety? | Dynavax DVAX | | 02/23/2013 05:42:14 PM |
| Hey Guys! What impact do you think stock offering will have? H | Welcome to the GENT board. GENT has the | | 05/31/2011 10:38:25 AM |
| I haven't been around here for years...and can't f | Biotech Valuation | 5 | 03/23/2011 04:28:05 PM |
| I don't know much about Kelly Martin's personal ha | Elan Corporation, plc (ELN) | 1 | 02/23/2010 12:45:04 PM |
| Arthur, Elan is a study in how not to run a pharma | Elan Corporation, plc (ELN) | | 02/23/2010 11:39:16 AM |
| Elan now needs to begin emphasizing results. The | Elan Corporation, plc (ELN) | 1 | 02/23/2010 10:35:15 AM |
| Dew Diligence, my point was that risk clearly does | Elan Corporation, plc (ELN) | | 09/09/2009 12:43:13 PM |
| I have to take issue with the notion that risk inc | Elan Corporation, plc (ELN) | 2 | 09/09/2009 08:09:37 AM |
| Lionbridge continues to throw off real cash every | LIOX - Globalization for the Internet | | 08/14/2009 10:57:11 AM |
| That comparison between US sales of Copaxone and Tysabri is amazing. IMO, it sp | Elan Corporation, plc (ELN) | 1 | 08/11/2009 01:17:16 AM |
| Filo,
If the data shows that AAB is extremely efficacious at 0.5 and/or 1.0 a | Elan Corporation, plc (ELN) | 1 | 07/26/2008 11:10:07 PM |
| quidditch, to me it looks like another flurizan but replace nsaid with antihista | Elan Corporation, plc (ELN) | 1 | 07/21/2008 05:35:58 PM |
| Was absolutely not making fun of the idea of IVIG being effective - but you just | momo-T/FIF | | 07/14/2008 06:33:46 PM |
| rkrw,
Not around much anymore, but really nice to see your "name" come up on | momo-T/FIF | | 07/13/2008 10:12:55 PM |
| Robohogs, if that is the same report that someone posted on Yahoo, then I think | Elan Corporation, plc (ELN) | 2 | 07/06/2008 06:45:53 PM |
| Those results look terrible. | Elan Corporation, plc (ELN) | | 06/29/2008 10:26:54 PM |
| Rituxan would be a nice option for patients who are refractory to Tysabri. But, | Elan Corporation, plc (ELN) | | 02/18/2008 01:58:48 PM |
| Maybe Tom. I think that it would be unwise for any beta interferon manufacturer | Elan Corporation, plc (ELN) | 3 | 02/10/2008 10:11:59 AM |
| With the clinical trials showing more melanoma in the placebo groups than drug g | Elan Corporation, plc (ELN) | 6 | 02/09/2008 11:40:54 PM |
| COGS depends on many factors, of course, but the range is 11% (Biogen's Avonex) | ZymoGenetics ZGEN | | 01/19/2008 11:53:12 PM |
| Steve, there was an article on www.cnn.com last week wherein an analyst posited | Elan Corporation, plc (ELN) | | 01/13/2008 09:10:22 PM |
| Happy New Year Quid! Just checked in now - sorry for the tardy reply.
CD d | Elan Corporation, plc (ELN) | | 01/07/2008 11:26:18 PM |
| Fred,
I think Lars Ekman said that the results would be released within 2 wee | Elan Corporation, plc (ELN) | 4 | 12/24/2007 02:48:20 PM |
| Peter, I forgot to say "Hello!"
I hope you are very well, and hope that Jim | Biotech Valuation | | 12/15/2007 08:15:21 AM |
| Would FTY-720 and BG-12 and Campath qualify as MS drugs that could not meet the | Biotech Valuation | | 12/15/2007 02:40:14 AM |
| SI Bob,
The math is as follows:
$67m one time charges
$10m+ reduction in | Elan Corporation, plc (ELN) | | 07/26/2007 01:14:23 PM |
| Steve, it will be great to have another potential treatment for AD available. T | Elan Corporation, plc (ELN) | | 07/25/2007 12:35:10 AM |
| Who are these people? Are they bad biotech analysts? | Biotech Valuation | | 06/27/2007 09:54:19 PM |
| zeta, I think that Elan is severely undervalued:
1. Its AD programs are very | Elan Corporation, plc (ELN) | 1 | 06/26/2007 01:43:44 PM |
| previous post: whole = hole. Sometimes fingers type without connecting to brain | Elan Corporation, plc (ELN) | | 06/20/2007 09:44:01 AM |
| I don't know of course about precise Tysabri trends, but there is a major whole | Elan Corporation, plc (ELN) | | 06/19/2007 09:36:37 PM |
| This last week was the rebound from the shortened Memorial Day week. On the who | Elan Corporation, plc (ELN) | | 06/19/2007 05:21:51 PM |
| Rob, sales revenue is ramping. There will likely be just under 4,000 additional | Elan Corporation, plc (ELN) | | 06/19/2007 06:59:49 AM |
| Well I can't believe that I didn't know that DD. I am actually surprised becaus | Elan Corporation, plc (ELN) | | 06/19/2007 06:51:56 AM |
| <b>This is not true:</b> "The U.S. Food and Drug Administration recommends that | Elan Corporation, plc (ELN) | 3 | 06/18/2007 09:45:57 AM |
| Looks like the big news yesterday was that Lilly's gamma secretase inhibitor for | Elan Corporation, plc (ELN) | 7 | 06/13/2007 07:32:33 AM |
| Avonex, Rebic, Betaseron are all in $22K-$24K/year range. Tysabri is $28K/yr.
| Elan Corporation, plc (ELN) | | 06/04/2007 07:20:07 AM |
| Lee, Elan has control of its own destiny. The loss carryforward does the opposi | Elan Corporation, plc (ELN) | | 06/01/2007 10:53:57 PM |
| Was a nice positive piece of research put out by GS too, with a buy recommendati | Elan Corporation, plc (ELN) | | 05/25/2007 07:39:20 AM |
| Zeta, that was very kind. We are just making up for our behaviour before you ca | Elan Corporation, plc (ELN) | | 05/22/2007 09:17:32 AM |
| Exactly Lee. | Elan Corporation, plc (ELN) | | 05/21/2007 03:53:10 PM |
| Fred, IMO after 270 patients, 2+ years for many of them, there are many fewer un | Elan Corporation, plc (ELN) | | 05/21/2007 02:24:54 PM |
| quidditch, the companies have definitely seen the data but not the unblinded dat | Elan Corporation, plc (ELN) | | 05/21/2007 02:22:18 PM |
| Jon, there is no way that Elan sells to Biogen for anything less than $45. Ther | Elan Corporation, plc (ELN) | | 05/19/2007 11:17:47 AM |
| Rituxan has quite the safety record? Since Tysabri was withdrawn I think there | Elan Corporation, plc (ELN) | | 05/08/2007 11:54:37 PM |
| Bob, it appears that Tysabri is at least as effective at inducing remission as t | Elan Corporation, plc (ELN) | | 04/28/2007 06:29:07 PM |
| Bob:
Here is Cochrane on natalizumab for CD:
http://www.cochrane.org/reviews | Elan Corporation, plc (ELN) | | 04/26/2007 03:57:56 PM |
| Bob, as Fred pointed out, Tysabri has been shown to be at least as effective as | Elan Corporation, plc (ELN) | | 04/25/2007 06:35:42 PM |
| I do not see an acceleration in signup or infusion Fred: over 9 weeks only 2,000 | Elan Corporation, plc (ELN) | | 04/25/2007 10:47:43 AM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
